Trends and In-Hospital Mortality for Perioperative Myocardial Infarction After the Introduction of a Diagnostic Code

Daniel S Rubin1, Antonia Z Lin2, R Parker Ward3

  • 1From the Department of Anesthesia and Critical Care, The University of Chicago Medical Center, Chicago, Illinois.

Anesthesia and Analgesia
|February 16, 2023
PubMed

Insights

The introduction of a diagnostic code for type 2 myocardial infarction did not increase perioperative myocardial infarction frequency. Type 2 myocardial infarction diagnosis was not linked to higher in-hospital mortality, but further research on interventions is needed.

Area of Science:

  • Cardiology
  • Healthcare Analytics
  • Surgical Outcomes

Background:

  • Perioperative myocardial infarction (MI) frequency is declining, but prior studies focused only on Type 1 MI.
  • This study examines the impact of the Type 2 MI diagnostic code on overall MI frequency and in-hospital mortality.
  • Utilizing the International Classification of Diseases 10th revision (ICD-10-CM) code for Type 2 MI provides a more comprehensive understanding.

Purpose of the Study:

  • To evaluate the overall frequency of perioperative myocardial infarction after the introduction of the ICD-10-CM code for Type 2 MI.
  • To determine the independent association between Type 2 MI and in-hospital mortality.
  • To analyze the trends in MI frequency and types following the diagnostic code implementation.

Main Methods:

  • A longitudinal cohort study using the National Inpatient Sample (NIS) from 2016-2018.
  • Included hospital discharges with major surgical procedures (intrathoracic, intraabdominal, suprainguinal vascular surgery).
  • Used segmented and multivariable logistic regression to analyze MI frequency trends and mortality associations.

Main Results:

  • Overall MI incidence was 0.76% (1,801,239 discharges).
  • The Type 2 MI code introduction did not significantly alter the trend in perioperative MI frequency.
  • Type 2 MI was not associated with increased in-hospital mortality (OR, 1.11; 95% CI, 0.81-1.53), unlike STEMI and NSTEMI.

Conclusions:

  • The introduction of the Type 2 MI diagnostic code did not lead to an increase in perioperative MI frequency.
  • Type 2 MI diagnosis showed no association with increased in-patient mortality in this cohort.
  • Further research is required to identify optimal interventions for Type 2 MI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
17
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
21
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19